ODE-499

TREATMENT OF ADULT PATIENTS WITH NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME-POSITIVE CHRONICMYELOID LEUKEMIA (PH+ CML) IN CHRONIC PHASE (CP), EXCLUDING PATIENTS WITH THE T315I MUTATION